Does Omega-3/Omega-6 Balance Affect Eye Disease Risk in Premature Babies via the Gut?
This paper looks at earlier research suggesting that giving extremely premature infants a supplement combining arachidonic acid (AA) and DHA was linked to a lower risk of severe retinopathy of prematurity, an eye disease that can affect very early babies.
The authors explored whether changes in the infants’ gut bacteria might explain this link. They found that AA:DHA supplementation was associated with some differences in the types of bacteria present and in predicted bacterial functions, but the evidence was not strong enough to say that these gut microbiome changes actually caused the reduction in eye disease severity.
The researchers conclude that more detailed studies—tracking the microbiome more frequently over time and accounting for antibiotics, feeding methods, and other clinical factors—are needed before anyone can confidently say the gut microbiome is the mechanism connecting AA:DHA supplementation to eye health outcomes in preterm infants.
What this means for you
This is an early, exploratory analysis, not proof of cause and effect. It highlights an interesting pattern worth further study but does not confirm that omega-3/omega-6 supplementation improves eye health in premature infants through gut bacteria changes—more rigorous research is needed before drawing firm conclusions.
Ready to start? The ALP Protocol delivers the EPA & DHA doses used in the research.
Start the ALP ProtocolThis summary is for educational purposes only and is not medical advice. Always talk to your healthcare provider before making changes to your supplement routine.